OBJECTIVE: This cross sectional study aimed to characterize fears of recurrence among women newly diagnosed with gynecologic cancer. The study also evaluated models predicting the impact of recurrence fears on psychological distress through social and cognitive variables. METHODS:Women (N=150) who participated in a randomized clinical trial comparing a coping and communication intervention to a supportive counseling intervention to usual care completed baseline surveys that were utilized for the study. The survey included the Concerns about Recurrence Scale (CARS), Beck Depression Inventory (BDI), Impact of Event Scale (IES), and measures of social (holding back from sharing concerns and negative responses from family and friends) and cognitive (positive reappraisal, efficacy appraisal, and self-esteem appraisal) variables. Medical data was obtained via medical chart review. RESULTS:Moderate-to-high levels of recurrence fears were reported by 47% of the women. Younger age (p<.01) and functional impairment (p<.01) correlated with greater recurrence fears. A social-cognitive model of fear of recurrence and psychological distress was supported. Mediation analyses indicated, that as a set, the social and cognitive variables mediated the association between fear of recurrence and both depression and cancer-specific distress. Holding back and self-esteem showed the strongest mediating effects. CONCLUSION: Fears of recurrence are prevalent among women newly diagnosed with gynecologic cancer. Social and cognitive factors play a role in women's adaptation to fears and impact overall psychological adjustment. These factors may be appropriate targets for intervention.
RCT Entities:
OBJECTIVE: This cross sectional study aimed to characterize fears of recurrence among women newly diagnosed with gynecologic cancer. The study also evaluated models predicting the impact of recurrence fears on psychological distress through social and cognitive variables. METHODS:Women (N=150) who participated in a randomized clinical trial comparing a coping and communication intervention to a supportive counseling intervention to usual care completed baseline surveys that were utilized for the study. The survey included the Concerns about Recurrence Scale (CARS), Beck Depression Inventory (BDI), Impact of Event Scale (IES), and measures of social (holding back from sharing concerns and negative responses from family and friends) and cognitive (positive reappraisal, efficacy appraisal, and self-esteem appraisal) variables. Medical data was obtained via medical chart review. RESULTS: Moderate-to-high levels of recurrence fears were reported by 47% of the women. Younger age (p<.01) and functional impairment (p<.01) correlated with greater recurrence fears. A social-cognitive model of fear of recurrence and psychological distress was supported. Mediation analyses indicated, that as a set, the social and cognitive variables mediated the association between fear of recurrence and both depression and cancer-specific distress. Holding back and self-esteem showed the strongest mediating effects. CONCLUSION: Fears of recurrence are prevalent among women newly diagnosed with gynecologic cancer. Social and cognitive factors play a role in women's adaptation to fears and impact overall psychological adjustment. These factors may be appropriate targets for intervention.
Authors: D Bodurka-Bevers; K Basen-Engquist; C L Carmack; M A Fitzgerald; J K Wolf; C de Moor; D M Gershenson Journal: Gynecol Oncol Date: 2000-09 Impact factor: 5.482
Authors: Lari B Wenzel; James P Donnelly; Jeffery M Fowler; Rana Habbal; Thomas H Taylor; Noreen Aziz; David Cella Journal: Psychooncology Date: 2002 Mar-Apr Impact factor: 3.894
Authors: Tina R Norton; Sharon L Manne; Stephen Rubin; John Carlson; Enrique Hernandez; Mitchell I Edelson; Norman Rosenblum; David Warshal; Cynthia Bergman Journal: J Clin Oncol Date: 2004-03-01 Impact factor: 44.544
Authors: Donna M Posluszny; Mary Amanda Dew; Ellen Beckjord; Dana H Bovbjerg; John E Schmidt; Carissa A Low; Amy Lowery; Stephanie A Nutt; Sarah R Arvey; Ruth Rechis Journal: J Health Psychol Date: 2015-04-06
Authors: Sharon L Manne; Shannon Myers-Virtue; Deborah A Kashy; Melissa Ozga; David Kissane; Carolyn Heckman; Mark Morgan Journal: Psychooncology Date: 2016-12-22 Impact factor: 3.894
Authors: Sharon L Manne; Shannon Myers-Virtue; Deborah Kashy; Melissa Ozga; David Kissane; Carolyn Heckman; Stephen C Rubin; Norman Rosenblum Journal: Cancer Nurs Date: 2015 Sep-Oct Impact factor: 2.592
Authors: Loni Ledderer; Karen la Cour; Ole Mogensen; Erik Jakobsen; René Depont Christensen; Jakob Kragstrup; Helle Ploug Hansen Journal: Patient Date: 2013 Impact factor: 3.883
Authors: Rebecca N Adams; Catherine E Mosher; Andrea A Cohee; Timothy E Stump; Patrick O Monahan; George W Sledge; David Cella; Victoria L Champion Journal: Psychooncology Date: 2016-03-10 Impact factor: 3.894
Authors: Sharon L Manne; Deborah A Kashy; Shannon Virtue; Kevin R Criswell; David W Kissane; Melissa Ozga; Carolyn J Heckman; Jerod Stapleton; Lorna Rodriguez Journal: Qual Life Res Date: 2018-08-20 Impact factor: 4.147
Authors: Brian D Gonzalez; Sharon L Manne; Jerod Stapleton; Shannon Myers-Virtue; Melissa Ozga; David Kissane; Carolyn Heckman; Mark Morgan Journal: Support Care Cancer Date: 2016-10-19 Impact factor: 3.603
Authors: Caroline S Dorfman; Eneka Lamb; Alyssa Van Denburg; Anava A Wren; Mary Scott Soo; Kaylee Faircloth; Vicky Gandhi; Rebecca A Shelby Journal: J Psychosoc Oncol Date: 2018-01-11